Scaffold Searching of FDA and EMA-Approved Drugs Identifies Lead Candidates for Drug Repurposing in Alzheimer’s Disease

Scaffold Searching of FDA and EMA-Approved Drugs Identifies Lead Candidates for Drug Repurposing in Alzheimer’s Disease

Clinical trials of novel therapeutics for Alzheimer’s Disease (AD) have consumed a significant amount of time and resources with largely negative results. Repurposing drugs already approved by the Food and Drug Administration (FDA), European Medicines Agency (EMA), or Worldwide for another indicatio...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Sergey Shityakov, Ekaterina V. Skorb, Carola Y. Förster, Thomas Dandekar
Μορφή:	Άρθρο
Γλώσσα:	English
Έκδοση:	Frontiers Media S.A. 2021-10-01
Σειρά:	Frontiers in Chemistry
Θέματα:	scaffold search approved drugs drug repurposing alzheimer's disease chemical similarity molecular modeling
Διαθέσιμο Online:	https://www.frontiersin.org/articles/10.3389/fchem.2021.736509/full

Παρόμοια τεκμήρια

In silico repurposing of FDA-approved drugs as multi-target inhibitors of glioblastoma
ανά: Ridwan Abiodun Salaam, κ.ά.
Έκδοση: (2025-03-01)

A Transcriptomics-Based Bioinformatics Approach for Identification and In Vitro Screening of FDA-Approved Drugs for Repurposing against Dengue Virus-2
ανά: Madhura Punekar, κ.ά.
Έκδοση: (2022-09-01)

Editorial: Adopting drug repurposing to overcome drug resistance in cancer
ανά: Eswar Shankar, κ.ά.
Έκδοση: (2023-04-01)

Network-based drug repurposing for potential stroke therapy
ανά: Qihui Wu, κ.ά.
Έκδοση: (2023-01-01)

Approved drugs successfully repurposed against Leishmania based on machine learning predictions
ανά: Rafeh Oualha, κ.ά.
Έκδοση: (2024-09-01)

Repurposing FDA‐Approved Compounds for the Discovery of Glutaminyl Cyclase Inhibitors as Drugs Against Alzheimer's Disease
ανά: Dr. Chenshu Xu, κ.ά.
Έκδοση: (2021-09-01)

Screening of an FDA-Approved Library for Novel Drugs against <i>Y. pestis</i>
ανά: David Gur, κ.ά.
Έκδοση: (2021-01-01)

Trends in FDA drug approvals over last 2 decades: An observational study
ανά: Angelika Batta, κ.ά.
Έκδοση: (2020-01-01)

Computational Drug Repurposing Based on a Recommendation System and Drug–Drug Functional Pathway Similarity
ανά: Mengting Shao, κ.ά.
Έκδοση: (2022-02-01)

Potential COVID-19 papain-like protease PLpro inhibitors: repurposing FDA-approved drugs
ανά: Valentina L. Kouznetsova, κ.ά.
Έκδοση: (2020-09-01)

Repurposable Drugs for Immunotherapy and Strategies to Find Candidate Drugs
ανά: Norihiro Sakai, κ.ά.
Έκδοση: (2023-08-01)

Drugs, Devices, and the FDA: Part 1
ανά: Gail A. Van Norman, MD
Έκδοση: (2016-04-01)

Trends and Perspectives of Biological Drug Approvals by the FDA: A Review from 2015 to 2021
ανά: Alexander C. Martins, κ.ά.
Έκδοση: (2022-09-01)

Towards Drug Repurposing in Cancer Cachexia: Potential Targets and Candidates
ανά: Joana M. O. Santos, κ.ά.
Έκδοση: (2021-10-01)

An empirical analysis of overall survival in drug approvals by the US FDA (2006–2023)
ανά: Josh Elbaz, κ.ά.
Έκδοση: (2024-04-01)

Repurposing FDA-approved drugs targeting FZD10 in nasopharyngeal carcinoma: insights from molecular dynamics simulations and experimental validation
ανά: Chawalit Ngernsombat, κ.ά.
Έκδοση: (2024-12-01)

Computational and Experimental Drug Repurposing of FDA-Approved Compounds Targeting the Cannabinoid Receptor CB1
ανά: Emanuele Criscuolo, κ.ά.
Έκδοση: (2023-12-01)

Repurposing of Drug Candidates for Treatment of Skin Cancer
ανά: Hernán Cortés, κ.ά.
Έκδοση: (2021-01-01)

Pathways for non-manufacturers to drive generic drug repurposing for cancer in the U.S.
ανά: Devon Crittenden, κ.ά.
Έκδοση: (2024-10-01)

Drugs approved by CDSCO, India in 2015
ανά: K Parushuram Naik1 , V Sai Lakshmi2 , J Jyothirmai3
Έκδοση: (2016-04-01)

Repurposing FDA-approved drugs against multiple proteins of SARS-CoV-2: An in silico study
ανά: Alfred Olaoluwa Akinlalu, κ.ά.
Έκδοση: (2021-09-01)

A review of new drugs approved by the food and drug administration in 2022
ανά: Arjun Swaminathan, κ.ά.
Έκδοση: (2023-10-01)

Drug repurposing to tackle parainfluenza 3 based on multi-similarities and network proximity analysis
ανά: Xinyue Chen, κ.ά.
Έκδοση: (2024-10-01)

Repurposed Drugs in Gastric Cancer
ανά: Diana Araújo, κ.ά.
Έκδοση: (2022-12-01)

An Insight into FDA Approved Antibody-Drug Conjugates for Cancer Therapy
ανά: Juliana T. W. Tong, κ.ά.
Έκδοση: (2021-09-01)

Repurposing Loperamide as an Anti-Infection Drug for the Treatment of Intracellular Bacterial Pathogens
ανά: Hongtao Liu, κ.ά.
Έκδοση: (2024-08-01)

Drug Repositioning for Effective Prostate Cancer Treatment
ανά: Beste Turanli, κ.ά.
Έκδοση: (2018-05-01)

Asymmetric Synthesis of US-FDA Approved Drugs over Five Years (2016–2020): A Recapitulation of Chirality
ανά: Rekha Tamatam, κ.ά.
Έκδοση: (2023-02-01)

Design and synthesis of fluorine aromatic scaffolds containing drugs approved by the US FDA from 2002 to 2022
ανά: Pengfei Xu, κ.ά.
Έκδοση: (2024-01-01)

Pharmacokinetic Profile of a Drug Repurposing Candidate for the Treatment of Cutaneous Leishmaniasis (in Silico)
ανά: Arlindo Gonzaga Branco Junior, κ.ά.
Έκδοση: (2024-08-01)

Molecular docking of monkeypox (mpox) virus proteinase with FDA approved lead molecules
ανά: M.Valan Arasu, κ.ά.
Έκδοση: (2023-05-01)

Antiviral Activity of Approved Antibacterial, Antifungal, Antiprotozoal and Anthelmintic Drugs: Chances for Drug Repurposing for Antiviral Drug Discovery
ανά: Abdulaziz L, κ.ά.
Έκδοση: (2022-03-01)

The Repurposing of FDA-Approved Drugs as FtsZ Inhibitors against <i>Mycobacterium tuberculosis</i>: An In Silico and In Vitro Study
ανά: Andrea Michel Tovar-Nieto, κ.ά.
Έκδοση: (2024-07-01)

In Vitro Drug Repurposing: Focus on Vasodilators
ανά: Eduarda Ribeiro, κ.ά.
Έκδοση: (2023-02-01)

A review of the clinical efficacy of FDA-approved antibody‒drug conjugates in human cancers
ανά: Kaifeng Liu, κ.ά.
Έκδοση: (2024-03-01)

Drug Repurposing for Schistosomiasis: Combinations of Drugs or Biomolecules
ανά: Maria João Gouveia, κ.ά.
Έκδοση: (2018-02-01)

Editorial: Drug Repurposing
ανά: Pan Pantziarka, κ.ά.
Έκδοση: (2019-07-01)

Large-scale detection of drug off-targets: hypotheses for drug repurposing and understanding side-effects
ανά: Matthieu Chartier, κ.ά.
Έκδοση: (2017-04-01)

Prospects for repurposing CNS drugs for cancer treatment
ανά: Mohamed Abdelaleem, κ.ά.
Έκδοση: (2019-04-01)

Melatonin as a Repurposed Drug for Melanoma Treatment
ανά: Rachana Pathipaka, κ.ά.
Έκδοση: (2023-01-01)